2005
DOI: 10.1016/j.amjcard.2005.01.085
|View full text |Cite
|
Sign up to set email alerts
|

Predictors of Left Main or Three-Vessel Disease in Patients Who Have Acute Coronary Syndromes With Non–ST-Segment Elevation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
66
2
9

Year Published

2007
2007
2020
2020

Publication Types

Select...
4
4

Relationship

1
7

Authors

Journals

citations
Cited by 90 publications
(79 citation statements)
references
References 15 publications
2
66
2
9
Order By: Relevance
“…[7][8][9] Troponin T on admission is a well-established marker of high risk in patients with NSTE-ACS, 18,19 whereas ST-segment elevation in lead aVR is more useful for identifying patients with LM/3VD. The results of the Troponin T was positive on admission.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…[7][8][9] Troponin T on admission is a well-established marker of high risk in patients with NSTE-ACS, 18,19 whereas ST-segment elevation in lead aVR is more useful for identifying patients with LM/3VD. The results of the Troponin T was positive on admission.…”
Section: Discussionmentioning
confidence: 99%
“…Early (ie, before angiography), accurate, non-invasive identification of patients with LM/3VD in whom CABG is most likely to be indicated is thus a major clinical issue with important therapeutic implications. We have previously demonstrated that ST-segment elevation in lead aVR and positive-troponin T on admission (especially the former) are useful predictors of the risk of LM/3VD in patients with NSTE-ACS, [7][8][9] however, QRS duration in previous studies was not considered. Although electrocardiographic assessment of myocardial ischemia is usually based on ST-segment deviation, QRS prolongation has been shown to be more sensitive than ST-segment changes for the detection of myocardial ischemia.…”
mentioning
confidence: 99%
“…From the study, the sensitivity of ST-segment elevation in lead aVR for predicting LMCA obstruction was determined to be 81% and the specificity to be 80%. Kosuge et al 1 found that STsegment elevation greater than 0.5 mm in lead aVR to be the strongest predictor of LMCA or three-vessel disease, superior to the presence of ST-segment depression in other leads in patients with non-ST-segment elevation-ACSs who underwent coronary angiography in the acute phase. Statistical analysis of this finding revealed a sensitivity of 78%, a specificity of 86%, a positive predictive value of 57%, and a negative predictive value of 95%.…”
Section: Short Communication Continuedmentioning
confidence: 99%
“…There were 475 who underwent angiography; of those with C1 mm of STE in aVR (n = 92), 48 % had three-vessel disease and 18 % had LMCA disease, compared to 21 and 4 % for those with \1 mm STE in aVR [74]. Kosuge et al [75] studied 310 patients with ACS without STE. They found that STE in aVR of C0.5 mm was the strongest predictor of LMCA or three-vessel disease, with an OR of 19.7, and it identified LMCA or three-vessel disease with 78 % sensitivity and 86 % specificity, and a PPV and NPV of 57 and 95 %.…”
Section: Lead Avr In Non-ste-acsmentioning
confidence: 99%
“…More recent claims that ST elevation in aVR is independent of ST depression in these opposing leads have not been substantiated for non-STEMI, though this appears to be true for STEMI (see above). Nevertheless, it is convenient to use one lead with ST elevation (aVR) as a substitute for many others with ST depression, such that, in non-STE-ACS, the degree of ST elevation in aVR correlates with the number of leads with ST depression, the depth of the ST depression, and the sum of ST depressions [67,[73][74][75][76]. In all studies, measurements of the ST segment are at 80 ms after the J-point for ST depression and 20 ms after the J-point for ST elevation, both relative to the TP segment.…”
Section: Lead Avr In Non-ste-acsmentioning
confidence: 99%